FDA “Safety First” Initiative, Agency’s Requests Draw Doubts From DeLauro

FDA is implementing the Safety First initiative to "ensure that significant post-market safety issues are our highest priority," according to acting Center for Drug Evaluation and Research Director Janet Woodcock